Embleema
New York
About Embleema
We empower patients to reclaim ownership of their medical data, connect directly with research studies, and be compensated for sharing their data. We are setting the standard for Real World Evidence, an achievement that will substantially reduce the amount of time and costs for new life-saving drugs to reach patients with rare diseases. By improving the collection, quality and sharing of RWE, we enable the healthcare system to move away from the current linear process of drug approvals to a new iterative model where trustworthy digital health data is shared in real time between patients, manufacturers and regulators. Want to find out more? Get in touch!
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.7M
- Funding stage: Early Stage Venture
- Last round: Non-Equity Assistance (Dec 2019)
- Website: embleema.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Hospital
Social Profiles
Canonical: https://fsome.com/organization/embleema-78760 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.